Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherAccelerated Communication

Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels

Wienke Lange, Jan Geißendörfer, Anne Schenzer, Joachim Grötzinger, Guiscard Seebohm, Thomas Friedrich and Michael Schwake
Molecular Pharmacology February 2009, 75 (2) 272-280; DOI: https://doi.org/10.1124/mol.108.052282
Wienke Lange
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Geißendörfer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Schenzer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Grötzinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guiscard Seebohm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Friedrich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schwake
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 75 no. 2 272-280
DOI 
https://doi.org/10.1124/mol.108.052282
PubMed 
19015229

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received October 3, 2008
  • Accepted November 17, 2008
  • Published online January 21, 2009.

Article Versions

  • Earlier version (November 17, 2008 - 08:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Wienke Lange,
  2. Jan Geißendörfer,
  3. Anne Schenzer,
  4. Joachim Grötzinger,
  5. Guiscard Seebohm,
  6. Thomas Friedrich and
  7. Michael Schwake
  1. Institute of Biochemistry, Christian-Albrechts-University Kiel, Kiel, Germany (W.L., A.S., J.Gr., M.S.); Technical University of Berlin, Institute of Chemistry, Berlin, Germany (W.L., J.Ge., T.F.); Lehrstuhl für Biochemie I-Rezeptorbiochemie, Ruhr-University Bochum, Bochum, Germany (G.S.); and Physiologisches Institut I, University of Tübingen, Tübingen, Germany (G.S.)
  1. Address correspondence to:
    Michael Schwake, Institute of Biochemistry, Christian-Albrechts-University Kiel, Olshausenstrasse 40, D-24098 Kiel, Germany. E-mail: mschwake{at}biochem.uni-kiel.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2008 to February 2023

AbstractFullPdf
Nov 2008320104
Dec 200824068
Jan 2009782378
Feb 2009744877
Mar 2009393447
Apr 2009382939
May 2009161618
Jun 2009251616
Jul 2009271714
Aug 200914815
Sep 2009181315
Oct 2009191317
Nov 2009171619
Dec 20091945
Jan 201032917
Feb 2010442536
Mar 2010391217
Apr 2010422720
May 2010111012
Jun 2010142123
Jul 2010401012
Aug 2010151512
Sep 2010202621
Oct 2010222323
Nov 2010163022
Dec 2010161510
Jan 2011171620
Feb 2011251525
Mar 2011241620
Apr 2011121515
May 2011151922
Jun 201162421
Jul 2011261016
Aug 2011172627
Sep 2011183217
Oct 2011192820
Nov 2011232928
Dec 2011141426
Jan 2012192726
Feb 2012303052
Mar 2012212628
Apr 2012282830
May 2012191935
Jun 2012292221
Jul 2012152320
Aug 2012151816
Sep 2012263325
Oct 2012241822
Nov 2012202315
Dec 2012172713
Jan 2013252416
Feb 2013183316
Mar 201315189
Apr 2013433335
May 2013352819
Jun 2013141915
Jul 201361210
Aug 2013141618
Sep 201325104
Oct 2013191411
Nov 201314167
Dec 20139108
Jan 2014272216
Feb 20148912
Mar 2014112512
Apr 2014221314
May 2014121211
Jun 2014101711
Jul 201417479
Aug 201492110
Sep 201411410
Oct 2014142010
Nov 2014363322
Dec 2014241313
Jan 20157144
Feb 201581510
Mar 2015221323
Apr 2015102210
May 201519218
Jun 2015232223
Jul 2015231413
Aug 2015182711
Sep 2015171515
Oct 2015102113
Nov 2015181216
Dec 2015141213
Jan 2016191816
Feb 2016162113
Mar 2016201220
Apr 2016111813
May 2016272118
Jun 2016545
Jul 2016171412
Aug 2016172212
Sep 2016131823
Oct 20163279
Nov 201673516
Dec 201654425
Jan 20171415
Feb 201755320
Mar 2017104115
Apr 2017102718
May 2017123726
Jun 2017122712
Jul 201711357
Aug 201711387
Sep 201710238
Oct 201792713
Nov 2017102614
Dec 2017144716
Jan 201825318
Feb 201811245
Mar 2018143716
Apr 2018113614
May 201882916
Jun 201823321
Jul 201871616
Aug 20180206
Sep 201812115
Oct 201822711
Nov 201846820
Dec 201838184
Jan 2019471513
Feb 2019481910
Mar 2019191514
Apr 201917615
May 2019241017
Jun 20193546
Jul 201916511
Aug 2019641115
Sep 20196575
Oct 20193545
Nov 20194375
Dec 20191786
Jan 20201316
Feb 20201942
Mar 20202774
Apr 20204666
May 20205997
Jun 20201803
Jul 20203053
Aug 20201325
Sep 20202321
Oct 202038810
Nov 2020933
Dec 20203046
Jan 20211973
Feb 20212984
Mar 20212111
Apr 20213434
May 20214632
Jun 20212941
Jul 20212036
Aug 20214884
Sep 20211662
Oct 20212371
Nov 20212651
Dec 20213132
Jan 20223628
Feb 20223673
Mar 20222312
Apr 20223675
May 20223832
Jun 20224023
Jul 20223176
Aug 20223297
Sep 20226322
Oct 20226521
Nov 20224110
Dec 2022624
Jan 20232672
Feb 20231012

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 75 (2)
Molecular Pharmacology
Vol. 75, Issue 2
1 Feb 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherAccelerated Communication

Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels

Wienke Lange, Jan Geißendörfer, Anne Schenzer, Joachim Grötzinger, Guiscard Seebohm, Thomas Friedrich and Michael Schwake
Molecular Pharmacology February 1, 2009, 75 (2) 272-280; DOI: https://doi.org/10.1124/mol.108.052282

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherAccelerated Communication

Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels

Wienke Lange, Jan Geißendörfer, Anne Schenzer, Joachim Grötzinger, Guiscard Seebohm, Thomas Friedrich and Michael Schwake
Molecular Pharmacology February 1, 2009, 75 (2) 272-280; DOI: https://doi.org/10.1124/mol.108.052282
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAA Receptor Desensitization by Low GABA
  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
Show more Accelerated Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics